Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / articles / merck s best selling cancer drug meets one goal in l mwn benzinga

SGEN - Merck's Best Selling Cancer Drug Meets One Goal In Late-Stage Bladder Cancer Study | Benzinga

Seagen Inc.

Merck & Co Inc (NYSE: MRK) announced that the Phase 3 AMBASSADOR (A031501) trial (KEYNOTE-123) evaluating Keytruda met one of its dual primary endpoints of disease-free survival for the adjuvant treatment of localized muscle-invasive urothelial carcinoma and locally advanced urothelial carcinoma.

Also Read: Merck-Eisai ...

Full story available on Benzinga.com
Stock Information
Company Name: Seagen Inc.
Stock Symbol: SGEN
Market: NASDAQ
Website: seagen.com
Menu
SGEN SGEN Quote SGEN Short SGEN News SGEN Articles SGEN Message Board
Get SGEN Alerts

News, Short Squeeze, Breakout and More Instantly...